Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease.

Trial Profile

Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2013

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Bile duct diseases; Crohn's disease; Malabsorption syndromes
  • Focus Therapeutic Use
  • Acronyms COBAM
  • Most Recent Events

    • 01 Mar 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 28 Jun 2012 Other source identified and integrated: European Clinical Trials Database record EudraCT2009-010727-91.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top